Observational analysis highlights PML risk management in multiple sclerosis with natalizumab, suggesting precautions are necessary.
Natalizumab can be used for long-term treatment of patients with MS even with positive JCV index if recommended precautions such as EID and frequent brain MRIs are followed.
No takes yet. Share an insight, caveat, or question.
Szejko et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: